Healthcare & Life Sciences
Long Grove Pharmaceuticals
United States
About
Long Grove Pharmaceuticals, launched by Water Street in 2019, develops complex generic drug reformulations and addresses challenging manufacturing, supply chain, and regulatory pathways in niche markets. The company both develops products for its own portfolio and partners with healthcare organizations to create entities that lead development and regulatory approval on their behalf.
Explore Long Grove Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.